Reporter July 26 2013
Jul. 25, 2013—Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
Jul. 25, 2013—High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.
Jul. 24, 2013—The Vanderbilt Stroke and Cerebrovascular Service has received advanced certification as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association/American Stroke Association, one of only four in Tennessee.
Jul. 23, 2013—In order to more effectively meet the broadly diverse work/life needs across employees’ life phases, Vanderbilt is moving to a modernized benefits plan called flexPTO.